Research coauthored by RTI Health Solutions researchers will be presented at the 2021 North American Menopause Society (NAMS) Annual Meeting.
A postmarketing noninterventional study evaluating the risk of endometrial cancer in women who have been prescribed Imvexxy® - study design. Graham S, Constantine GD, Margulis AV, Saltus CW, Johannes CB, Kaye JA, Mirkin S. Poster
Real-world treatment and resource utilization for menopausal symptoms in the United States. DePree B, Houghton K, Shiozawa A, Esterberg E, King D, Kim J, Mancuso S. Poster